Catherine M. Vaczy

General Counsel, Caladrius Biosciences.

Companies

Genprex, Inc.EVP & Chief Strategy Officer Mar 16, 2020 to Apr 24, 2023¹
Caladrius BiosciencesGeneral counsel Jun 6, 2006 to Apr 14, 2015²
Caladrius BiosciencesVP & Gen Counsel Feb 8, 2007 to Feb 8, 2007³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Genprex, Inc. GNPX265,000 shares⁴$564.5K at $2.13Apr 21, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 21, 2023Bought 20,000 shares at $1.07 of Genprex, Inc.⁴
Feb 18, 2023Granted 245,000 shares of Genprex, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGenprex, Inc., EVP & Chief Strategy Officer
2
SEC EDGARCaladrius Biosciences, General counsel
3
SEC EDGARCaladrius Biosciences, VP & Gen Counsel
4
SEC EDGARGenprex, Inc. shares after the filing of Apr 21, 2023
5
SEC EDGARForm 4 filed Feb 22, 2023